These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 30997542)

  • 21. Chlorhexidine bathing in a tertiary care neonatal intensive care unit: impact on central line-associated bloodstream infections.
    Quach C; Milstone AM; Perpête C; Bonenfant M; Moore DL; Perreault T
    Infect Control Hosp Epidemiol; 2014 Feb; 35(2):158-63. PubMed ID: 24442078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The bundle "plus": the effect of a multidisciplinary team approach to eradicate central line-associated bloodstream infections.
    Walz JM; Ellison RT; Mack DA; Flaherty HM; McIlwaine JK; Whyte KG; Landry KE; Baker SP; Heard SO;
    Anesth Analg; 2015 Apr; 120(4):868-76. PubMed ID: 24149581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: a feasibility randomized controlled trial (the CLABSI trial).
    Webster J; Larsen E; Marsh N; Choudhury A; Harris P; Rickard CM
    J Hosp Infect; 2017 Jul; 96(3):223-228. PubMed ID: 28526171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-Effectiveness Analysis of a Transparent Antimicrobial Dressing for Managing Central Venous and Arterial Catheters in Intensive Care Units.
    Maunoury F; Motrunich A; Palka-Santini M; Bernatchez SF; Ruckly S; Timsit JF
    PLoS One; 2015; 10(6):e0130439. PubMed ID: 26086783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States.
    Ye X; Rupnow M; Bastide P; Lafuma A; Ovington L; Jarvis WR
    Am J Infect Control; 2011 Oct; 39(8):647-654. PubMed ID: 21641681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arterial catheter-related bloodstream infection: incidence, pathogenesis, risk factors and prevention.
    Safdar N; O'Horo JC; Maki DG
    J Hosp Infect; 2013 Nov; 85(3):189-95. PubMed ID: 24070632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study.
    Schwebel C; Lucet JC; Vesin A; Arrault X; Calvino-Gunther S; Bouadma L; Timsit JF
    Crit Care Med; 2012 Jan; 40(1):11-7. PubMed ID: 21926570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of skin antiseptic solutions on the incidence of catheter-related bloodstream infection: a systematic review and network meta-analysis.
    Masuyama T; Yasuda H; Sanui M; Lefor AK
    J Hosp Infect; 2021 Apr; 110():156-164. PubMed ID: 33529623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripherally InSerted CEntral catheter dressing and securement in patients with cancer: the PISCES trial. Protocol for a 2x2 factorial, superiority randomised controlled trial.
    Rickard CM; Marsh NM; Webster J; Gavin NC; Chan RJ; McCarthy AL; Mollee P; Ullman AJ; Kleidon T; Chopra V; Zhang L; McGrail MR; Larsen E; Choudhury MA; Keogh S; Alexandrou E; McMillan DJ; Mervin MC; Paterson DL; Cooke M; Ray-Barruel G; Castillo MI; Hallahan A; Corley A; Geoffrey Playford E
    BMJ Open; 2017 Jun; 7(6):e015291. PubMed ID: 28619777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of a chlorhexidine intravascular catheter gel dressing on short-term central venous catheters.
    Karpanen TJ; Casey AL; Whitehouse T; Nightingale P; Das I; Elliott TS
    Am J Infect Control; 2016 Jan; 44(1):54-60. PubMed ID: 26455868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial.
    Chan RJ; Northfield S; Larsen E; Mihala G; Ullman A; Hancock P; Marsh N; Gavin N; Wyld D; Allworth A; Russell E; Choudhury MA; Flynn J; Rickard CM
    Trials; 2017 Oct; 18(1):458. PubMed ID: 28978332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
    Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
    Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlorhexidine-based versus non-chlorhexidine dressings to prevent catheter-related bloodstream infections: An evidence-based review.
    Azzopardi A; Trapani J
    Nurs Crit Care; 2024 Jan; 29(1):191-195. PubMed ID: 36579384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of unit-wide chlorhexidine bathing in intensive care on bloodstream infection and drug-resistant organism acquisition.
    Urbancic KF; Mårtensson J; Glassford N; Eyeington C; Robbins R; Ward PB; Williams D; Johnson PD; Bellomo R
    Crit Care Resusc; 2018 Jun; 20(2):109-116. PubMed ID: 29852849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for the effectiveness of chlorhexidine bathing and health care-associated infections among adult intensive care patients: a trial sequential meta-analysis.
    Frost SA; Hou YC; Lombardo L; Metcalfe L; Lynch JM; Hunt L; Alexandrou E; Brennan K; Sanchez D; Aneman A; Christensen M
    BMC Infect Dis; 2018 Dec; 18(1):679. PubMed ID: 30567493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial.
    Clarke P; Soe A; Nichols A; Harizaj H; Webber MA; Linsell L; Bell JL; Tremlett C; Muthukumar P; Pattnayak S; Partlett C; King A; Juszczak E; Heath PT
    Arch Dis Child Fetal Neonatal Ed; 2024 Feb; 109(2):202-210. PubMed ID: 37907266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting zero catheter-related bloodstream infections in pediatric intensive care unit: a retrospective matched case-control study.
    Biasucci DG; Pittiruti M; Taddei A; Picconi E; Pizza A; Celentano D; Piastra M; Scoppettuolo G; Conti G
    J Vasc Access; 2018 Mar; 19(2):119-124. PubMed ID: 29148002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized trial on chlorhexidine dressings for the prevention of catheter-related bloodstream infections in neutropenic patients.
    Biehl LM; Huth A; Panse J; Krämer C; Hentrich M; Engelhardt M; Schäfer-Eckart K; Kofla G; Kiehl M; Wendtner CM; Karthaus M; Ullmann AJ; Hellmich M; Christ H; Vehreschild MJ
    Ann Oncol; 2016 Oct; 27(10):1916-22. PubMed ID: 27456299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chlorhexidine-Impregnated Dressings and Prevention of Catheter-Associated Bloodstream Infections in a Pediatric Intensive Care Unit.
    Düzkaya DS; Sahiner NC; Uysal G; Yakut T; Çitak A
    Crit Care Nurse; 2016 Dec; 36(6):e1-e7. PubMed ID: 27908954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One percent chlorhexidine-alcohol for preventing central venous catheter-related infection during intensive chemotherapy for patients with haematologic malignancies.
    Ohtake S; Takahashi H; Nakagawa M; Uchino Y; Miura K; Iriyama N; Nakayama T; Hatta Y; Takei M
    J Infect Chemother; 2018 Jul; 24(7):544-548. PubMed ID: 29627326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.